To schedule a new patient appointment call 844-CANCERNJ (844-226-2376)
To schedule a follow-up appointment call 732-235-7615
For all other inquiries call 732-235-2465.
It is my honor to join the faculty in the Division of Blood Disorders at Rutgers Cancer Institute of New Jersey and Robert Wood Johnson Medical School.
I received my undergraduate degree from New York University following which I matriculated from Rutgers Robert Wood Johnson Medical School. I completed an Internal Medicine internship and residency at Thomas Jefferson University Hospital in Philadelphia and returned to New Jersey to complete a fellowship in Hematology and Medical Oncology at Rutgers Cancer Institute of New Jersey/Robert Wood Johnson Medical School. During my fellowship, I was elected to serve as a chief fellow and participated in the Botswana-Rutgers Global Oncology Fellowship, with which I remain actively engaged in longitudinal curriculum development.
Navigating a new diagnosis of cancer can be overwhelming and life-changing for patients and their families. As a hematologist-oncologist, it is my privilege to advocate for my patients by not only helping them understand their diagnosis and treatment options but also by providing support and guidance. Being part of an NCI-designated Comprehensive Cancer Center in New Jersey allows me to provide my patients with personalized, state-of-the-art care through access to novel therapies and clinical trials to achieve the best possible outcomes.
My practice focuses on blood cancers including plasma cell disorders, leukemias, and bone marrow disorders. I have honed my interests by successfully participating in clinical research and am the author and co-author of numerous publications, reviews, abstracts, and presentations. I am actively involved in the development and execution of clinical trials. As a member of the Hematologic Malignancies Program, I am committed to providing comprehensive care with a patient-centered approach in collaboration with an exceptional multidisciplinary team of healthcare providers.
Blood Cancers, Multiple Myeloma, Plasma Cell Disorders, Acute and Chronic Leukemias, Myelodysplastic Syndrome, Myeloproliferative Disorders
July 11, 2024
Dr. Mansi Shah is very concerned about the patient's response to treatment.
June 6, 2024
Dr. Shah explains things in terms I can understand not a lot of medical jargon.
April 22, 2024
I'm very satisfied.
April 10, 2024
So satisfied and more at ease after appointment.
March 28, 2024
Dr. Shah and her entire Team - excellent.
Accepted Health Plan information is only as accurate as the most current information submitted. Prior to your appointment, it is advisable to verify with your insurance company they are still a participating plan prior to receiving services or care. Each plan is different and some provide different levels of coverage that could make a difference in your out-of-pocket costs. It is always best for the patient receiving care to contact their insurance company to obtain more information.
Blood Cancers: 101
During this interview for the EBC Radio Cancer Education Series, Dr. Mansi Shah shares an overview of blood cancers, most common types, symptoms, and treatment options.
Multiple Myeloma: More Common Than You Think
Multiple Myeloma is the second most common blood cancer in the United States, although it is not well known to the general public. Learn more
What is Multiple Myeloma?
Dr. Mansi Shah of Rutgers Cancer Institute, discusses multiple myeloma causes, treatment and research at NJ's ONLY NCI-designated Comprehensive Cancer Center. Watch here